# EDGAR Filing Document

**Accession Number:** 0000840715
**File Stem:** 0001753926-26-000897
**Filing Date:** 2026-5
**Character Count:** 100125
**Document Hash:** 3b94b6154eaebad09f12fed66cc4f6db
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001753926-26-000897.hdr.sgml**: 20260515

**ACCESSION NUMBER**: 0001753926-26-000897

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 73

**CONFORMED PERIOD OF REPORT**: 20260331

**FILED AS OF DATE**: 20260515

**DATE AS OF CHANGE**: 20260515

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** CLEARONE INC
- **CENTRAL INDEX KEY:** 0000840715
- **STANDARD INDUSTRIAL CLASSIFICATION:** TELEPHONE & TELEGRAPH APPARATUS [3661]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 870398877
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-33660
- **FILM NUMBER:** 26988596

**BUSINESS ADDRESS:**
- **STREET 1:** 7533 S CENTER VIEW CT #5311
- **CITY:** WEST JORDAN
- **STATE:** UT
- **ZIP:** 84084
- **BUSINESS PHONE:** 8019757200

**MAIL ADDRESS:**
- **STREET 1:** 7533 S CENTER VIEW CT #5311
- **CITY:** WEST JORDAN
- **STATE:** UT
- **ZIP:** 84084

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** CLEARONE COMMUNICATIONS INC
- **DATE OF NAME CHANGE:** 20020204

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** GENTNER COMMUNICATIONS CORP
- **DATE OF NAME CHANGE:** 19920703

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** GENTNER ELECTRONICS CORP
- **DATE OF NAME CHANGE:** 19910808

?xml version='1.0' encoding='ASCII'? clro-20260331.htm

**UNITED STATES SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, D.C. 20549**

**Form 10-Q**

(Mark One)

---

| | |
|:---|:---|
| ☒ | **QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934** |
|  | For the quarterly period ended <u>March 31, 2026</u> |
| ☐ | **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934** |
|  | For the transition period _______ to _______ |

---

Commission file number:**<u>001-33660</u>**

**CLEARONE, INC.**

(Exact name of registrant as specified in its charter)

---

| | |
|:---|:---|
| **Nevada** | **87-0398877** |
| (State or other jurisdiction of incorporation; reincorporated from Delaware effective on or about April 22, 2026 pursuant to the Plan of Conversion approved by stockholders on March 12, 2026 – see Note 1) | (I.R.S. employer identification number) |
| **7533 S CENTER VIEW CT #5311, WEST JORDAN, UT** | **84084** |
| (Address of principal executive offices) | (Zip Code) |

---

Registrant's telephone number, including area code: <u>(801) 975-7200</u>

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol(s)** | **Name of each exchange on which registered** |
| Common Stock, $0.001<br>| CLRO | The NASDAQ Capital Market |

---

Indicate by check whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☒ Yes ☐ No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). ☒ Yes ☐ No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act. (Check one):

---

| | |
|:---|:---|
| Larger Accelerated Filer ☐ | Accelerated Filer ☐  |
| Non-Accelerated Filer ☒ | Smaller Reporting Company ☒ |
|  | Emerging Growth Company ☐  |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Yes ☐ No

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ☐ Yes ☒No

The number of shares of ClearOne, Inc. common stock outstanding as of May 15, 2026 was 2,675,412.

------

[**Table of Contents**](#TOC)

**CLEARONE, INC.**

**QUARTERLY REPORT ON FORM 10-Q FOR THE QUARTER ENDEDMARCH 31, 2026**

**INDEX**

---

| | | |
|:---|:---|:---|
|  | [**PART I - FINANCIAL INFORMATION**](#BA_ITXHYI3BG000000000000000000000) |  |
| Item 1. | [Financial Statements](#BB_DACLJMO6HS00000000000000000000) | 3 |
|  | [Unaudited Condensed Consolidated Balance Sheets as of March 31, 2026 and December 31, 2025](#BC_67A6VPX3U800000000000000000000) | 3 |
|  | [Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss for the three months ended March 31, 2026 and 2025](#BD_G3RUEUCU2O00000000000000000000) | 4 |
|  | [Unaudited Condensed Consolidated Statements of Cash Flows for the Three months ended March 31, 2026 and 2025](#BE_OCDKM4QLA800000000000000000000) | 5 |
|  | [Unaudited Notes to Condensed Consolidated Financial Statements](#BF_IMSU8UN3GG00000000000000000000) | 7 |
| Item 2. | [Management's Discussion and Analysis of Financial Condition and Results of Operations](#BG_ZROYRYR1OG00000000000000000000) | 21 |
| Item 3. | [Quantitative and Qualitative Disclosures About Market Risk](#BH_U66773D7WW00000000000000000000) | 28 |
| Item 4. | [Controls and Procedures](#BI_L8KHXR82WW00000000000000000000) | 28 |
|  | [**PART II - OTHER INFORMATION**](#BJ_TSTI5UOPUO00000000000000000000) |  |
| Item 1. | [Legal Proceedings](#BK_UH0QH1ST6800000000000000000000) | 28 |
| Item 1A. | [Risk Factors](#BL_C8C33AXDV400000000000000000000) | 28 |
| Item 2. | [Unregistered Sales of Equity Securities and Use of Proceeds](#BM_PXV2XAM1KG00000000000000000000) | 29 |
| Item 3. | [Defaults Upon Senior Securities](#BN_EVKECWSW2800000000000000000000) | 29 |
| Item 4. | [Mine Safety Disclosures](#BO_VVB037J0C000000000000000000000) | 29 |
| Item 5. | [Other Information](#BP_0LWBX5JVNK00000000000000000000) | 29 |
| Item 6. | [Exhibits](#Bit6_1272025202146458) | 30 |

---

------

[**Table of Contents**](#TOC)

[**PART I - FINANCIAL INFORMATION**](#)

[**Item 1. FINANCIAL STATEMENTS**](#)

**CLEARONE, INC**

[**UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS**](#)

(Dollars in thousands, except par value)

---

| | | |
|:---|:---|:---|
|  | **March 31, 2026** | **December 31, 2025** |
| **ASSETS**  |  |  |
| Current assets:  |  |  |
| Cash and cash equivalents  | $756 | $220  |
| Restricted cash | 297 | 519 |
| Inventories, net  | 333  | 353  |
| Prepaid assets | 10 |  |
| Current assets related to discontinued operations | 276 | 604 |
| &nbsp;&nbsp;&nbsp;&nbsp; Total current assets  | 1672 | 1696  |
| Operating lease - right of use assets, net  | 321  | 494 |
| Long term assets related to discontinued operations | 24 | 109 |
| &nbsp;&nbsp;&nbsp;&nbsp; Total assets  | $2017 | $2299  |
| **LIABILITIES AND SHAREHOLDERS' EQUITY**  |  |  |
| Current liabilities:  |  |  |
| Accounts payable  | $64  | $30  |
| Accrued liabilities  | 415 | 649  |
| Current operating lease liability | 168 | 223 |
| Current liabilities related to discontinued operations | 228 | 585 |
| &nbsp;&nbsp;&nbsp;&nbsp; Total current liabilities  | 875  | 1487  |
| Long term operating lease liability  | 169  | 290 |
| Long-term liabilities related to discontinued operations  | 441  | 1236  |
| &nbsp;&nbsp;&nbsp;&nbsp; Total liabilities  | 1485  | 3013  |
| Shareholders' equity:  |  |  |
| Class B convertible preferred stock, par value $0.001, 5,100 shares authorized, — and — shares issued and outstanding, respectively |  |  |
| Common stock, par value $0.001, 150,000,000 shares authorized, 2,675,412 and 2,237,912 shares issued and outstanding, respectively | 3  | 2  |
| Additional paid-in capital  | 37500  | 35767  |
| Accumulated other comprehensive loss  | (341) | (340 ) |
| Accumulated deficit  | (36630) | (36143 ) |
| &nbsp;&nbsp;&nbsp;&nbsp; Total shareholders' equity  | 532 | (714) |
| &nbsp;&nbsp;&nbsp;&nbsp; Total liabilities and shareholders' equity  | $2017  | $2299 |

---

*See accompanying notes*

------

[**Table of Contents**](#TOC)

**CLEARONE, INC.**

[**UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND**](#)

**COMPREHENSIVE LOSS**

(Dollars in thousands, except per share amounts)

---

| | | |
|:---|:---|:---|
|  | **Three months ended March 31,** | **Three months ended March 31,** |
|  | **2026** | **2025** |
| Revenue  | $—  | $— |
| Cost of goods sold  | 70  | 27 |
| Gross profit (loss)  | (70) | (27) |
| Operating expenses:  |  |  |
| Sales and marketing  | —  |  |
| Research and product development  | —  |  |
| General and administrative  | 780  | 799  |
| Total operating expenses  | 780  | 799  |
| Operating loss  | (850) | (826) |
| Interest (expense) |  |  |
| Other income, net  |  | 12 |
| Loss from continuing operations before income taxes  | (850) | (814) |
| Provision for income taxes  |  |  |
| Loss from continuing operations | (850) | (814) |
| Income (loss) from discontinued operations, net of tax | 363 | (2020) |
| Net loss  | $(487) | $(2834) |
| Basic weighted average shares outstanding  | 2383745 | 1649904 |
| Diluted weighted average shares outstanding  | 2754160  | 1649904 |
| Basic income (loss) per share  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;From continuing operations | $(0.36) | $(0.49) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;From discontinued operations | 0.15 | (1.22) |
| Total | (0.21) | (1.71) |
| Diluted income (loss) per share  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;From continuing operations | $(0.31) | $(0.49) |
| &nbsp;&nbsp;&nbsp;&nbsp;From discontinued operations | 0.13 | (1.22) |
| Total | (0.18) | (1.71) |
| Comprehensive loss:  |  |  |
| &nbsp;&nbsp;&nbsp; Net loss  | $(487) | $(2834) |
| &nbsp;&nbsp;&nbsp; Change in foreign currency translation adjustment  | (10) | (13) |
| Comprehensive loss  | $(497) | $(2847) |

---

*See accompanying notes*

------

[**Table of Contents**](#TOC)

**CLEARONE, INC.**

[**UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS**](#)

(Dollars in thousands, except per share amounts)

---

| | | |
|:---|:---|:---|
|  | **Three months ended March 31,** | **Three months ended March 31,** |
|  | **2026** | **2025** |
| Cash flows from operating activities:  |  |  |
| Net loss  | $(487) | $(2834) |
| Adjustments to reconcile net loss to net cash used in operating activities: |  |  |
| &nbsp;&nbsp;&nbsp; Amortization of right-of-use assets | 173 | 78 |
| &nbsp;&nbsp;&nbsp; Share-based compensation expense  | —  | 23  |
| Changes in operating assets and liabilities:  |  |  |
| &nbsp;&nbsp;&nbsp;Inventories | 20 |  |
| &nbsp;&nbsp;&nbsp;Prepaid expenses and other assets | (10) |  |
| &nbsp;&nbsp;&nbsp; Accounts payable  | 34 | 187 |
| &nbsp;&nbsp;&nbsp; Accrued liabilities  | (234) | (18) |
| &nbsp;&nbsp;&nbsp; Operating lease liabilities | (176) | (80) |
| Net cash used in operating activities, continuing operations  | (680) | (2644) |
| Cash provided by (used in) operating activities, discontinued operations | (733) | 1212 |
| Cash flows from investing activities: |  |  |
| Net cash provided by investing activities, continuing operations |  |  |
| Cash used in investing activities, discontinued operations |  | (18) |
| Cash flows from financing activities:  |  |  |
| &nbsp;&nbsp;&nbsp; Proceeds from sale of stock  | 1750 | 1000 |
| &nbsp;&nbsp;&nbsp; Purchases of outstanding warrants | (22) |  |
| Net cash provided by financing activities, continuing operations  | 1728 | 1000 |
| Cash provided by financing activities, discontinued operations |  | 7 |
| Effect of exchange rate changes on cash and cash equivalents  | (1) | (13) |
| Net increase (decrease) in cash and cash equivalents  | 314 | (456) |
| Cash and cash equivalents at the beginning of the period  | 739  | 1417  |
| Cash and cash equivalents at the end of the period  | $1053 | $961 |

---

*See accompanying notes*

------

[**Table of Contents**](#TOC)

**CLEARONE, INC.**

**UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS**

(Dollars in thousands, except per share amounts)

The following is a summary of supplemental cash flow information:

---

| | | |
|:---|:---|:---|
|  | **Three months ended March 31,** | **Three months ended March 31,** |
|  | **2026** | **2025** |
| Cash paid for income taxes  | $1 | $— |

---

*See accompanying notes* 

------

[**Table of Contents**](#TOC)

**CLEARONE, INC.**

[**UNAUDITED NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**](#)

(Unaudited - Dollars in thousands, except per share amounts)

**1. Business Description, Basis of Presentation and Significant Accounting Policies**

***Business Description:***

ClearOne, Inc., together with its subsidiaries (collectively, "ClearOne" or the "Company"), was a global market competitor providing conferencing, collaboration, and AV streaming solutions supporting voice and visual communications. Following the October 24, 2025 disposition of certain intellectual property, product inventory, and non-exclusive rights to customer data to Biamp Systems, LLC, the Company no longer manufactures or sells products and maintains only limited continuing operations consisting of warranty and technical support for legacy products, collecting accounts receivable and recovering prepaid assets, public-company compliance, and evaluation of strategic alternatives. See discussion of going concern and discontinued operations below.

*Going Concern:*

The accompanying consolidated financial statements have been prepared assuming the Company will continue as a going concern. The Company has incurred significant losses, has negative cash flows from operations, and its continuing operations are limited and not expected to generate revenue at levels sufficient to fund ongoing costs. These conditions, together with the mandatory redemption obligation for the Class A Redeemable Preferred Stock (triggered by the closing of the Asset Sale on October 24, 2025), raise substantial doubt about the Company's ability to continue as a going concern within one year after the issuance date of these financial statements. Management is actively evaluating strategic alternatives intended to enhance stockholder value and improve liquidity. These alternatives may include one or more special transactions or other actions that maximize value for stockholders. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

***Basis of Presentation:***

The fiscal year for ClearOne is the twelve months ending on December 31. The condensed consolidated financial statements include the accounts of ClearOne and its subsidiaries. All significant inter-company accounts and transactions have been eliminated.

------

[**Table of Contents**](#TOC)

UNAUDITED NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in thousands, except per share amounts)

On October 24, 2025, the Company completed the sale of certain intellectual property, product inventory, and non-exclusive rights to customer data (the "Asset Sale"). The disposal represented a strategic shift that has had a major effect on the Company's operations and financial results. Accordingly, the related operating results are presented as discontinued operations in accordance with ASC 205-20 for all periods presented. Prior-period amounts in the unaudited condensed consolidated statements of operations and cash flows have been recast to conform to this presentation. See Note 2 — Discontinued Operations and Assets Held for Sale for additional information.

These accompanying interim unaudited condensed consolidated financial statements have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC") and are not audited. Certain information and footnote disclosures that are usually included in financial statements prepared in accordance with generally accepted accounting principles in the United States ("GAAP") have been either condensed or omitted in accordance with SEC rules and regulations. The accompanying condensed consolidated financial statements contain all adjustments, consisting of normal recurring accruals, necessary for a fair presentation of our financial position as of March 31, 2026 and December 31, 2025, the results of operations for the three months ended March 31, 2026 and 2025, and the cash flows for the three months ended March 31, 2026 and 2025. The results of operations for the three months ended March 31, 2026 and 2025 are not necessarily indicative of the results for a full-year period. These interim unaudited condensed consolidated financial statements should be read in conjunction with the financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2025 filed with the SEC.

On April 22, 2026 (subsequent to the balance sheet date), the Company completed its reincorporation from Delaware to Nevada by conversion pursuant to the Plan of Conversion approved by stockholders on March 12, 2026. The Company is now a Nevada corporation, and all references to the Company's governing law and stockholder rights in these financial statements should be read in light of Nevada law. See Note 15 — Subsequent Events for additional information.

***Reverse Stock Split:***

The Company completed a 1-for-15 reverse stock split of the Company's issued and outstanding common stock, par value $0.001 per share, effective at 5:00 p.m. Eastern Time on June 9, 2025. The common stock began trading on a split-adjusted basis on the Nasdaq Capital Market on June 10, 2025, under the symbol "CLRO" and a new CUSIP number of 18506U203. The reverse stock split was primarily intended to increase the per share market price of the common stock in order to regain compliance with the minimum bid price requirement for continued listing on the Nasdaq Capital Market. As a result of the reverse stock split, every 15 shares of issued and outstanding common stock were automatically combined into one share, with no fractional shares issued (any fractional interests were rounded up to the next whole share). The reverse stock split did not change the par value of the common stock or the authorized number of shares but reduced the number of issued and outstanding shares from approximately 26.0 million to approximately 1.7 million, with proportional adjustments to outstanding stock options, warrants, and shares reserved under equity incentive plans. For additional details, refer to the Company's Current Report on Form 8-K filed with the SEC on June 2, 2025, including the press release attached as Exhibit 99.1 thereto.

All share and per-share amounts in these condensed consolidated financial statements and related notes have been retroactively adjusted to reflect the reverse stock split for all periods presented.

***Restricted Cash***

The Company includes restricted cash with cash and cash equivalents when reconciling the beginning-of-period and end-of-period total amounts shown on the statement of cash flows, in accordance with ASU 2016-18.

As of March 31, 2026, restricted cash totaled $297 and consisted entirely of remaining proceeds from the $3,000 convertible note issued to First Finance Ltd. on June 20, 2025 (compared to $0 as of March 31, 2025). These funds are subject to enforceable contractual restrictions under Schedule 8.5 of the related Note Purchase Agreement, which requires disbursement only upon achievement of specified milestones for uses such as advisory fees, warrant holder payments, legal and audit expenses, staff costs, foreign subsidiary shutdown costs, and severance/PTO payments. The funds are held in a segregated account and are released only upon meeting these milestones. During the three months ended March 31, 2026, $222 was disbursed in accordance with the agreement, resulting in the ending restricted cash balance of $297. The Company expects the remaining restricted cash to be fully disbursed by December 2026 as milestones are achieved.

In contrast, the proceeds received from the March 2, 2026 Securities Purchase Agreement with First Finance Ltd. (totaling $1,750) are not subject to the same contractual disbursement restrictions. Following stockholder approval of the Company's reincorporation on March 12, 2026, these proceeds became available for general corporate purposes and are therefore classified within Cash and cash equivalents on the balance sheet. Restricted cash is presented as a current asset on the balance sheet and is included in the total cash, cash equivalents, and restricted cash amounts presented in the statement of cash flows. Changes in restricted cash are not reported as separate cash flow activities but are disclosed in this note.

------

[**Table of Contents**](#TOC)

UNAUDITED NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in thousands, except per share amounts)

***Product warranties***

**The Company provides assurance-type warranties on previously sold products and records a liability for the estimated cost to repair or replace products under warranty at the time of sale in accordance with ASC 460. The liability is based on historical claim experience, the nature of the underlying products, current information on repair costs and expected failure rates. The Company reviews warranty estimates each period and records adjustments to the liability when facts and circumstances indicate changes in expected claims or costs.**

***Significant Accounting Policies:***

The significant accounting policies were described in Note 1 to the audited consolidated financial statements included in the Company's annual report on Form 10-K for the year ended December 31, 2025. There have been no changes to these policies during the quarter ended March 31, 2026 that are of significance or potential significance to the Company, other than presentation of discontinued operations as described above and in Note 2.

Recent accounting pronouncements:

*ASU 2024-03, Income Statement—Reporting Comprehensive Income (Topic 220): Disaggregation of Income Statement Expenses*

In November 2024, the FASB issued ASU No. 2024-03, "Income Statement—Reporting Comprehensive Income (Topic 220): Disaggregation of Income Statement Expenses," which requires public business entities, such as the Company, to provide disaggregated disclosure of specific natural expense categories underlying certain income statement expense line items in the notes to the financial statements. The standard identifies five required natural expense categories for disaggregation—employee compensation, depreciation, amortization, inventory expense, and other manufacturing expenses—along with a residual "other" category for remaining amounts within relevant expense captions (e.g., cost of sales, selling, general and administrative expenses). ASU 2024-03 does not alter the expense captions presented on the face of the income statement but enhances footnote disclosures to improve transparency. The standard is effective for annual periods beginning after December 15, 2026, with early adoption permitted, and must be applied prospectively, though retrospective application is optional. An update in ASU 2025-01 clarified that interim period disclosures are not required until annual periods beginning after December 15, 2027. The Company is in the process of evaluating the impact of ASU 2024-03 on its consolidated financial statements. We expect adoption to necessitate modifications to our financial reporting processes and systems to capture and disclose the required disaggregated expense information in the footnotes. Management anticipates that this will enhance the granularity of expense disclosures but does not expect a material effect on our reported financial position or results of operations. We are reviewing our current expense classification practices and data collection capabilities to ensure compliance with the new requirements upon adoption.

The Company has determined that recently issued accounting standards, other than the above discussed, will not have a material impact on its consolidated financial position, results of operations or cash flows.

------

[**Table of Contents**](#TOC)

**UNAUDITED NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

(Dollars in thousands, except per share amounts)

**2.**Discontinued Operations and Assets Held for Sale** 

On October 24, 2025, the Company completed the sale of substantially all of its operating assets and intellectual property related to its product business to Biamp Systems, LLC (the "Asset Sale"). The transaction represented a strategic shift that had (and continues to have) a major effect on the Company's operations and financial results. Accordingly, the results of the disposed component are presented as discontinued operations in the accompanying condensed consolidated statements of operations and cash flows for all periods presented, in accordance with ASC 205-20.

The disposal group was sold prior to December 31, 2025. As a result, the carrying value of the remaining disposal group was $0 at both December 31, 2025 and March 31, 2026. The Company continues to fulfill limited warranty and technical support obligations for legacy products sold prior to the Asset Sale. These activities are reflected in continuing operations, along with residual collections. Liability settlements are reflected within discontinued operations.

For a full description of the Asset Sale, including the Strategic Plan approved by the Board in September 2025, the mandatory redemption of the Class A Redeemable Preferred Stock (classified as a current liability — see Note 3), and the classification of assets and liabilities as held for sale, see Note 2 to the Company's Annual Report on Form 10-K for the year ended December 31, 2025. Major line items of results of discontinued operations (unaudited):

---

| | | |
|:---|:---|:---|
|  | **Three months ended March 31,** | **Three months ended March 31,** |
|  | **2026** | **2025** |
| Revenue | $—<br>| $2313 |
| Cost of goods sold | 88 | 2165 |
| Gross profit (loss) | (88) | 148 |
| Operating expenses | 264 | 2168 |
| Other expenses | 78 |  |
| Loss from discontinued operations before income taxes | (430) | (2020) |
| Benefit for income taxes | 793 |  |
| Income (Loss) from discontinued operations, net of tax | $363 | $(2020) |

---

The following table disaggregates the Company's revenue into primary product groups:

---

| | | |
|:---|:---|:---|
|  | **Three months ended March 31,** | **Three months ended March 31,** |
|  | **2026** | **2025** |
| Audio conferencing  | $— | $953 |
| Microphones  |  | 1118 |
| Video products  |  | 242 |
|  | $— | $2313 |

---

The following table disaggregates the Company's revenue into major regions:

---

| | | |
|:---|:---|:---|
|  | **Three months ended March 31,** | **Three months ended March 31,** |
|  | **2026** | **2025** |
| North and South America  | $— | $960 |
| Asia Pacific (includes Middle East, India and Australia)  |  | 1188 |
| Europe and Africa  |  | 165 |
|  | $— | $2313 |

---

------

[**Table of Contents**](#TOC)

UNAUDITED NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited - Dollars in thousands, except per share amounts)

Assets grouped into discontinued operations (unaudited):

---

| | | |
|:---|:---|:---|
|  | **March 31, 2026** | **December 31, 2025** |
| Accounts receivable, net | $50 | $391 |
| Inventories, net |  |  |
| Prepaids and other current assets | 226 | 213 |
| Property, plant and equipment, net |  | 80 |
| Other long-term assets | 24 | 29 |
| Total assets | $300 | $713 |

---

Liabilities grouped into discontinued operations (unaudited):

---

| | | |
|:---|:---|:---|
|  | **March 31, 2026** | **December 31, 2025** |
| Accounts payable | $3 | $63 |
| Accrued liabilities, current | 225 | 521 |
| Other long-term liabilities | 441 | 1236 |
| Total liabilities | $669 | $1820 |

---

Management concluded the disposal constitutes a component and a strategic shift since it eliminates significant revenue-generating activities. The Company will continue to provide product support and warranty services as it pursues a Strategic Transaction in fiscal 2026.

**3.**Capital Structure: Class A Redeemable Preferred Stock**

On July 18, 2025, the Company issued 2,069,065 shares of Class A Redeemable Preferred Stock as a one-time special stock dividend to holders of common stock and common stock equivalents of record as of July 11, 2025 (one Class A share for each common share and common stock equivalent then outstanding). The Class A shares have a par value of $0.001 per share and rank senior to common stock. 2,069,066 shares are authorized and were issued and outstanding as of March 31, 2026.

Pursuant to the Certificate of Designation, the Class A shares are mandatorily redeemable at par value upon the occurrence of an Asset Sale (as defined). The Asset Sale to Biamp Systems, LLC closed on October 24, 2025. As a result, the redemption obligation became unconditional and the Class A shares are classified as a current liability at par value ($2) as of March 31, 2026 in accordance with ASC 480-10-S99.

The redemption occurred on April 21, 2026. The ultimate redemption amount equaled the actual net proceeds received from the Asset Sale after permitted expenses. See Note 15 — Subsequent Events for additional information.

------

[**Table of Contents**](#TOC)

**UNAUDITED NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

(Unaudited - Dollars in thousands, except per share amounts)

**4. Debt and Equity: Conversion of Convertible Note** 

On June 20, 2025, the Company issued a $3,000 convertible note to First Finance Ltd. The note accrued interest at 10% per annum and was mandatorily convertible into shares of newly designated Class B Convertible Preferred Stock upon the issuance of Class A Redeemable Preferred Stock (which occurred on July 18, 2025).

On July 21, 2025, the convertible note (together with accrued interest) automatically converted into 3,026 shares of Class B Convertible Preferred Stock. The conversion was recognized in equity with no gain or loss. The conversion ratio was fixed at issuance and qualified for the ASC 815-40 own-equity scope exception.

As of March 31, 2026, there is no outstanding convertible note liability. All Class B Convertible Preferred Stock has been converted or redeemed (see Note 11 – Shareholders' Equity).

This conversion was a non-cash financing activity and is disclosed in the supplemental cash flow information (in the nine months ended September 30, 2025).

**5. Warrants Repurchased (and Related Party)**

September 2025 Repurchases

During September 2025, the Company repurchased and cancelled all then-outstanding warrants as follows:

* Intracoastal Capital, LLC – 6,039 underlying shares (September 2, 2025) for $4 

* Lind Global Fund II, LP – 24,155 underlying shares (September 10, 2025) for $16 

* Edward Dallin Bagley (related party) – 18,940 underlying shares (September 17, 2025) for $12 

* Edward Bryan Bagley – 3,788 underlying shares (September 16, 2025) for $2

All repurchased warrants were cancelled upon settlement and accounted for as equity transactions with no effect on the statement of operations.

*March 2026 Repurchase*

On March 9, 2026, the Company entered into a Warrant Repurchase Agreement with CVI Investments, Inc. pursuant to which the Company repurchased certain outstanding common stock purchase warrants originally issued on September 12, 2021. The repurchased warrants were exercisable for an aggregate of 24,155 shares of common stock. The Company paid an aggregate cash purchase price of $22 ($0.911 per underlying share). Upon settlement, the warrants were cancelled and are of no further force or effect.

As of March 31, 2026, 624,702 warrants are outstanding (187,202 from prior financings that were not repurchased and 437,500 new warrants issued on March 2, 2026 to First Finance Ltd., see Note 11). The Company did not issue any other new warrants during the quarter ended March 31, 2026.

The repurchase from Edward Dallin Bagley was approved by the Board of Directors in accordance with the Company's related person transaction policy. No amounts were outstanding with Mr. Bagley related to these warrants as of March 31, 2026.

**6. Revenue Information**

The Company recognized no revenue from continuing operations for the three months ended March 31, 2026 (and the comparable 2025 period). All revenue formerly reported by product group and geographic region is now presented within discontinued operations (see Note 2).

**7. Income (Loss) per share**

Basic net income (loss) per share is computed by dividing net income (loss) attributable to common stockholders by the weighted-average number of common shares outstanding during the period. Diluted net income (loss) per share includes the effect of potentially dilutive common shares (e.g., convertible securities, warrants, options) using the if-converted and treasury stock methods, as applicable. All share and per-share amounts have been retroactively adjusted to reflect the Company's reverse stock split (see Note 1).

------

[**Table of Contents**](#TOC)

UNAUDITED NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited - Dollars in thousands, except per share amounts)

As discussed in Note 2 — Discontinued Operations and Assets Held for Sale, the Company presents basic and diluted income (loss) per share separately for continuing operations, discontinued operations, and total, for each period presented.

The Company issued Class A Redeemable Preferred Stock via a special stock dividend in July 2025 (see Note 3). Class A is redeemable for net proceeds of a qualifying asset sale and does not participate in current-period earnings or losses other than its redemption preference. Management concluded that Class A is not a participating security for purposes of the two-class method for the periods presented; therefore, no allocation of earnings (loss) was made to Class A in computing loss per share.

The following table sets forth the computation of basic and diluted income (loss) per common share:

---

| | | |
|:---|:---|:---|
|  | **Three months ended March 31,** | **Three months ended March 31,** |
|  | **2026** | **2025** |
| Numerator:  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Loss from continuing operations  | $(850) | $(814) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Income (loss) from discontinued operations  | $363 | $(2020) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net loss  | $(487) | $(2834) |
| Denominator:  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Basic weighted average shares outstanding  | 2383745 | 1649904 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dilutive common stock equivalents using treasury stock method  | 370415 |  |
| Diluted weighted average shares outstanding  | 2754160 | 1649904 |
| Basic income (loss) per share  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; From continuing operations | $(0.36) | $(0.49) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; From discontinued operations | $0.15 | $(1.22) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total | $(0.21) | $(1.71) |
| Diluted income (loss) per share  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; From continuing operations | $(0.31) | $(0.49) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; From discontinued operations | $0.13 | $(1.22) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total | $(0.18) | $(1.71) |
| Weighted average options, warrants and convertibles outstanding  | 370415 | 372740 |
| Anti-dilutive options, warrants and convertibles not included in the computation  |  | 372740 |

---

------

[**Table of Contents**](#TOC)

**UNAUDITED NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

(Unaudited - Dollars in thousands, except per share amounts)

**8. Inventories**

As of September 30, 2025, significant inventories were classified as assets held for sale and are therefore excluded from continuing operations disclosures. In October 2025, significant inventories were sold, and no inventory remains in assets related to discontinued operations as of December 31, 2025 and March 31, 2026. See Note 2. Some inventories were retained to service warranty liabilities.

Inventories, net of reserves, as of March 31, 2026 and December 31, 2025 consisted of the following:

---

| | | |
|:---|:---|:---|
|  | **March 31, 2026** | **December 31, 2025** |
| Current:  |  |  |
| &nbsp;&nbsp;&nbsp; Finished goods  | $333  | $353  |

---

**9. Leases**

Rent expense is recognized on a straight-line basis over the period of the lease taking into account future rent escalation and holiday periods.

Rent expense for three months ended March 31, 2026 and 2025 was as follows:

---

| | | |
|:---|:---|:---|
|  | **Three months ended March 31,**  | **Three months ended March 31,**  |
|  | **2026**  | **2025**  |
| Rent expense |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; Continuing operations | $— | $— |
| &nbsp;&nbsp;&nbsp;&nbsp; Discontinued operations | 110 | 112 |
| Total rent expense  | $110  | $112  |

---

As of March 31, 2026, the Company had one remaining operating lease — the Edgewater Corporate Park facility at 5225 Wiley Post Way, Salt Lake City, Utah (approximately 9,402 square feet), which supported administrative, sales, marketing, customer support, and warranty operations. The lease was scheduled to expire in February 2028.

Subsequent to March 31, 2026, on April 7, 2026, the Company terminated the Edgewater lease for a $300 termination fee (see Note 15 — Subsequent Events). The other two leases (Gainesville, FL and the Salt Lake City warehouse at 363 West 2720 South) had already been terminated prior to March 31, 2026.

------

[**Table of Contents**](#TOC)

UNAUDITED NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in thousands, except per share amounts)

Supplemental cash flow information related to leases was as follows:

---

| | | |
|:---|:---|:---|
|  | **Three months ended March 31,** | **Three months ended March 31,** |
|  | **2026** | **2025** |
| Cash paid for amounts included in the measurement of lease liabilities  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Operating cash flows from operating leases | $(176) | $(92) |
| Right-of-use assets obtained in exchange for lease obligations: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Operating leases | $— | $— |

---

Supplemental balance sheet information related to leases was as follows:

---

| | | |
|:---|:---|:---|
|  | **March 31, 2026** | **December 31, 2025** |
| Operating lease right-of-use assets  | $321 | $494 |
| Current portion of operating lease liabilities, included in accrued liabilities | $168 | $223 |
| Operating lease liabilities, net of current portion  | 169 | 290 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total operating lease liabilities  | $337 | $513 |
| Weighted average remaining lease term for operating leases (in years) | 1.92 | 2.17 |
| Weighted average discount rate for operating leases | 6.80% | 6.76% |

---

The following represents maturities of operating lease liabilities as of March 31, 2026:

---

| | |
|:---|:---|
| **Years ending December 31,**  |  |
| &nbsp;&nbsp;&nbsp; 2026 (Remainder)  | $139 |
| &nbsp;&nbsp;&nbsp; 2027 | 190  |
| &nbsp;&nbsp;&nbsp; 2028 | 31  |
| &nbsp;&nbsp;&nbsp; 2029 | —  |
| &nbsp;&nbsp;&nbsp; 2030 | —  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total lease payments  | 360  |
| &nbsp;&nbsp;&nbsp; Less: Imputed interest  | (23) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total  | $337 |

---

**10. Convertible Note Payable**

On June 20, 2025, the Company issued a $3,000 convertible note to First Finance Ltd. The note accrued interest at 10% per annum and was mandatorily convertible into Class B Convertible Preferred Stock upon the issuance of Class A Redeemable Preferred Stock (which occurred July 18, 2025).

On July 21, 2025, the note (together with accrued interest) automatically converted into 3,026 shares of Class B Convertible Preferred Stock. The conversion was recognized in equity with no gain or loss recorded.

As of March 31, 2026, there is no outstanding convertible note liability. See Note 4 – Debt and Equity for additional information

------

[**Table of Contents**](#TOC)

**UNAUDITED NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

(Dollars in thousands, except per share amounts)

**11. Shareholders' Equity**

---

| | | |
|:---|:---|:---|
|  | **Three months ended March 31,** | **Three months ended March 31,** |
|  | **2026** | **2025** |
| **Preferred stock, common stock and additional paid-in capital**  |  |  |
| Balance, beginning of period  | $35769  | $31696  |
| Return of dividend  | 6 |  |
| Repurchase of warrants | (22) |  |
| Issuance of common stock and warrants, net | 1750 | 1000 |
| Share-based compensation expense  | —  | 23  |
| Proceeds from employee stock purchase plan  |  | 7 |
| Balance, end of period  | $37503  | $32726  |
| **Accumulated other comprehensive loss**  |  |  |
| Balance, beginning of period  | $(340) | $(306) |
| Foreign currency translation adjustment  | (1) | (13) |
| Balance, end of period  | $(341) | $(319) |
| **Accumulated deficit**  |  |  |
| Balance, beginning of period  | $(36143) | $(10059) |
| Net income (loss) – discontinued operations | 363 | (814) |
| Net loss – continuing operations | (850) | (2020 ) |
| Balance, end of period  | $(36630) | $(12893 ) |
| Total shareholders' equity  | $532 | $19514 |

---

Issue of Common Stock

On February 26, 2025 the Company entered into a securities purchase agreement with Edward D. Bagley, pursuant to which the Company agreed to issue and sell, in a private placement at-the-market offering of 133,334 shares of the Company's common stock, par value $0.001 per share, at a purchase price of $7.50 per share of Common Stock. The Company received $1,000 in cash in connection with the sale. Mr. Bagley is an affiliate of the Company and was the Company's single largest stockholder.

------

[**Table of Contents**](#TOC)

UNAUDITED NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in thousands, except per share amounts)

***Amendments to Certificate of Incorporation and Reverse Stock Split***

At the special meeting of stockholders held on May 30, 2025, stockholders approved amendments to the Certificate of Incorporation to: (i) increase the authorized number of shares of common stock from 50,000,000 to 150,000,000; (ii) authorize 50,000,000 shares of "blank check" preferred stock; (iii) effect a reverse stock split at a ratio between 1-for-10 and 1-for-15, with the exact ratio to be determined by the Board of Directors; and (iv) eliminate the prohibition on stockholder action by written consent and to allow such actions. Following stockholder approval, on June 4, 2025, the Company filed a Certificate of Amendment to its Certificate of Incorporation to effect these changes, including the selection of a 1-for-15 reverse stock split ratio, which became effective at 5:00 p.m. Eastern Time on June 9, 2025. The common stock began trading on a split-adjusted basis on the Nasdaq Capital Market on June 10, 2025, under the symbol "CLRO" and a new CUSIP number of 18506U203. The reverse stock split was primarily intended to increase the per share market price of the common stock in order to regain compliance with the minimum bid price requirement for continued listing on the Nasdaq Capital Market. As a result of the reverse stock split, every 15 shares of issued and outstanding common stock were automatically combined into one share, with no fractional shares issued (any fractional interests were converted to one whole share). The reverse stock split did not change the par value of the common stock but reduced the number of issued and outstanding shares from approximately 26.0 million to approximately 1.7 million, with proportional adjustments to outstanding stock options, warrants, and shares reserved under equity incentive plans. All share and per-share amounts in these condensed consolidated financial statements and related notes have been retroactively adjusted to reflect the reverse stock split for all periods presented.

For additional details, including the Certificate of Amendment, refer to the Company's Current Report on Form 8-K filed with the SEC on June 2, 2025, including the press release attached as Exhibit 99.1 and the Certificate of Amendment attached as Exhibit 3.1 thereto.

 ***Preferred Stock Designations and Related Matters***

On June 24, 2025, the Company filed Certificates of Designation with the State of Delaware authorizing up to 2,069,066 shares of Class A Redeemable Preferred Stock and 5,100 shares of Class B Convertible Preferred Stock. The Class A Redeemable Preferred Stock, which ranks senior to common stock and is redeemable upon an Asset Sale (defined as the sale of all or substantially all of the Company's current assets and operations, which the Company is required to pursue using reasonable best efforts within 180 days of issuance), was issued on July 18, 2025 as a dividend to holders of common stock and common stock equivalents of record as of July 11, 2025. Net proceeds from any Asset Sale will be distributed pro rata to holders of Class A Redeemable Preferred Stock. The Class B Convertible Preferred Stock ranks senior to common stock and other equity (except Class A Redeemable Preferred Stock), with specific rights including dividends, voting (on an as-converted basis), and liquidation preferences.

Additionally, effective June 20, 2025, the Board of Directors was expanded from four to five members, with Eric Boehnke and Youngsun Park (a/k/a Sunny Park), nominees of First Finance Ltd., appointed as directors to serve until the next annual meeting or until their successors are elected and qualified. Neither appointee has any material arrangements or family relationships with the Company requiring disclosure under Item 404(a) of Regulation S-K, and they will receive standard director compensation.

For additional details, refer to the Company's Current Report on Form 8-K filed with the SEC on June 25, 2025, including the Certificates of Designation attached as Exhibits 3.1 and 3.2, the Note Purchase Agreement attached as Exhibit 10.1, and the Convertible Note attached as Exhibit 10.2 thereto.

***March 2, 2026 Private Placement***

***On March 2, 2026, the Company entered into a Securities Purchase Agreement with First Finance Ltd. the Company's largest stockholder, pursuant to which the Company issued and sold 437,500 shares of common stock at a purchase price of $4.00 per share and a warrant to purchase up to 437,500 additional shares of common stock at an exercise price of $5.00 per share. The warrant has a two-year term expiring on March 2, 2028 and becomes exercisable on September 2, 2026. The warrant is classified in stockholders' equity in accordance with ASC 815-40. The Company received gross proceeds of $1,750. The fair value of the warrants was determined using the Black-Scholes option pricing model. The Company allocated the proceeds between the common stock and the warrants based on their relative fair values. The portion of the proceeds allocated to the warrants, $618, was recorded in additional paid-in capital – warrants. The Company also entered into a Registration Rights Agreement with First Finance Ltd. providing for the registration of the shares and warrant shares for resale.***

***The issuance was made in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933, as amended, and Rule 506(b) promulgated thereunder. The transaction was approved by the Board of Directors (with interested directors recusing themselves as appropriate).***

------

[**Table of Contents**](#TOC)

**UNAUDITED NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

(Dollars in thousands, except per share amounts)

**12. Share-based Compensation**

The Company uses judgment in determining the fair value of the share-based payments on the date of grant using an option-pricing model with assumptions regarding a number of highly complex and subjective variables. These variables include, but are not limited to, the risk-free interest rate of the awards, the expected life of the awards, the expected volatility over the term of the awards, and the expected dividends of the awards. The Company uses the Black-Scholes option pricing model to determine the fair value of share-based payments granted under the guidelines of ASC Topic 718.

A summary of the stock option activity under the Company's plans for the three months ended March 31, 2026, is as follows:

---

| | | |
|:---|:---|:---|
|  | **Number of shares**  | **Weighted average exercise price**  |
| **Options outstanding at beginning of year**  | 19716  | $35.33  |
| &nbsp;&nbsp;&nbsp; Granted  | —  |  |
| Less:  |  |  |
| &nbsp;&nbsp;&nbsp; Canceled or expired  | 14382 | 12.58  |
| **Options outstanding at March 31, 2026**  | 5334  | 96.60  |
| Options exercisable at end of March 31, 2026  | 5334 | $96.60  |

---

As of March 31, 2026, the total remaining unrecognized compensation cost related to non-vested stock options, net of forfeitures, was $0.

Share based compensation expense has been recorded as follows:

---

| | | |
|:---|:---|:---|
|  | **Three months ended March 31,** | **Three months ended March 31,** |
|  | **2026** | **2025** |
| Cost of goods sold  | $—  | $—  |
| Sales and marketing  |  | 1  |
| Research and product development  | —  | 4  |
| General and administrative  | —  | 18  |
|  | $—  | $23  |

---

------

[**Table of Contents**](#TOC)

**UNAUDITED NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

(Dollars in thousands, except per share amounts)

**13. Income Taxes**

The Company recorded a full valuation allowance against U.S Federal and State deferred tax assets, which results in no income tax benefit for losses in these jurisdictions. The full domestic valuation allowance was recorded as management concluded that it is more likely than not that these deferred tax assets are not realizable due to the Company's recent pre-tax losses and other sources of negative evidence. Provision for income taxes for the three months ended March 31, 2026 mostly represents income tax expense (benefit) recorded for jurisdictions outside the United States.

Effective July 1, 2007, the Company adopted the accounting standards related to uncertain tax positions. This standard requires that tax positions be assessed using a two-step process. A tax position is recognized if it meets a "more likely than not" threshold and is measured at the largest amount of benefit that is greater than 50 percent likely of being realized. Uncertain tax positions must be reviewed at each balance sheet date. Liabilities recorded as a result of this analysis must generally be recorded separately from any current or deferred income tax accounts.

The total amount of unrecognized tax benefits for continuing operations as of March 31, 2026, that would favorably impact our effective tax rate if recognized was $417. As of March 31, 2026, we accrued $80 in interest and penalties related to unrecognized tax benefits. We account for interest expense and penalties for unrecognized tax benefits as part of our income tax provision.

Although we believe our estimates are reasonable, we can make no assurance that the final tax outcome of these matters will not be different from that which we have reflected in our historical income tax provisions and accruals. Such difference could have a material impact on our income tax provision and operating results in the period in which we make such determination.

A reconciliation of the beginning and ending amount of liabilities associated with uncertain tax positions is as follows:

---

| | |
|:---|:---|
|  | **Quarter ended March 31,** |
|  | **2026** |
| Balance – beginning of year | $1030 |
| &nbsp;&nbsp;&nbsp;&nbsp;Additions based on tax positions related to current quarter |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Reductions for tax positions of prior years | (61) |
| &nbsp;&nbsp;&nbsp;&nbsp;Lapse in statues of limitations | (595) |
| Uncertain tax positions, ending balance | $374 |

---

The Company's U.S. federal income tax returns for 2022 through 2025 are subject to examination. The Company also files in various state and foreign jurisdictions. With few exceptions, the Company is no longer subject to federal, state, or non-U.S. income tax examinations by tax authorities for years prior to 2022.

------

[**Table of Contents**](#TOC)

**UNAUDITED NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

(Dollars in thousands, except per share amounts)

**14. Operating Segment** 

The Company operates as one operating segment. Operating segments are defined as components of an entity for which separate financial information is regularly evaluated by the chief operating decision maker ("CODM"), which is the Company's Chief Executive Officer, in deciding how to allocate resources and assess performance. The Company's CODM evaluates financial information and resources and assesses the performance of these resources on a consolidated basis. There is no expense or asset information that is supplemental to information disclosed within the consolidated financial statements, that is regularly provided to the CODM. The allocation of resources and assessment of performance of the operating segment is based on consolidated net loss and functional expenses as reported on our consolidated statements of operations and comprehensive loss. Because the Company operates as one operating segment, financial segment information, including expense and asset information, can be found in the consolidated financial statements.

**15. Subsequent Events**

***April 1, 2026 – CEO Transition***

The Company entered into a letter agreement with Derek L. Graham to provide for his continued service as Chief Executive Officer on a transitional consulting basis following the expiration of his employment agreement on March 31, 2026. Under the agreement, Mr. Graham provides consulting services for up to ten hours per week at a rate of $160 per hour while continuing to perform all functions of the CEO. The agreement has no fixed term and may be terminated by either party at any time.

***April 7, 2026 – Lease Termination and Nasdaq Notice***

The Company entered into a lease termination agreement with Edgewater Corporate Park, LLC, terminating its lease at 5225 Wiley Post Way, Salt Lake City, Utah for a $300 termination fee. The termination released the Company from approximately $376 in remaining rent and $53 in restoration charges. See Note 9 – Leases for additional details.

On the same date, the Company received a letter from Nasdaq informing it that it is not in compliance with the continued listing standards under Nasdaq Marketplace Rule 5550(b). The Company has 45 calendar days (until May 22, 2026) to submit a compliance plan. See "Risk Factors" in Item 1A for additional information.

***April 10, 2026 – Class A Preferred Redemption***

The Company's Board of Directors approved the redemption of all 2,069,065 outstanding shares of Class A Redeemable Preferred Stock on April 21, 2026 at the par value of $0.001 per share (aggregate redemption amount of approximately $2). See Note 3 – Class A Redeemable Preferred Stock (Current Liability) for additional details.

***April 22, 2026 – Nevada Reincorporation***

The Company completed its reincorporation from Delaware to Nevada by conversion, effective on or about April 22, 2026, pursuant to the Plan of Conversion approved by stockholders on March 12, 2026. The Company is now a Nevada corporation. See Note 1 – Business Description for additional information regarding the impact on governing law and stockholder rights.

------

[**Table of Contents**](#TOC)

[**Item 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS**](#)

This report on Form 10-Q includes "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). All statements in this report, other than statements of historical fact, are forward-looking statements for purposes of these provisions, including any projections of earnings, revenues or other financial items, any statements of the plans and objectives of management for future operations, any statements concerning proposed new products or services, any statements regarding future economic conditions or performance, and any statements of assumptions underlying any of the foregoing. All forward-looking statements included in this report are made as of the date hereof and are based on information available to us as of such date. We assume no obligation to update any forward-looking statement. In some cases, forward-looking statements can be identified by the use of terminology such as "may," "will," "expects," "plans," "anticipates," "intends," "believes," "estimates," "potential," or "continue," or the negative thereof or other comparable terminology. Although we believe that the expectations reflected in the forward-looking statements contained herein are based upon reasonable assumptions at the time made, there can be no assurance that any such expectations or any forward-looking statement will prove to be correct. Our actual results will vary, and may vary materially, from those projected or assumed in the forward-looking statements. Future financial condition and results of operations, as well as any forward-looking statements, are subject to inherent risks and uncertainties, many of which we cannot predict with accuracy and some of which we might not anticipate, including, without limitation, descriptions of our review of strategic alternatives and the timing and impact of any potential strategic transactions, the proposed development, manufacturing, and sale of our products; statements that describe expectations regarding pricing trends, our ability to collect accounts receivable and recover prepaid assets, our ability to regain compliance with the continued listing standards of the Nasdaq Capital Market; statements with respect to the anticipated sources of and need for future financing; and statements with respect to future strategic plans, goals, and objectives and forecasts of future growth and value; and other factors referred to in our reports filed with the SEC, including our Annual Report on Form 10-K for the year ended December 31, 2025. All subsequent forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by these cautionary statements. Additional factors that may have a direct bearing on our operating results are discussed in Part I, Item 1A "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2025. Beginning September 30, 2025, we classified substantially all operating assets related to our product business as held for sale and began presenting the results of that component as discontinued operations. Accordingly, the discussion below focuses on continuing operations unless otherwise indicated. See Note 2.

**BUSINESS OVERVIEW**

ClearOne, Inc. (the "Company," "we," "us," or "our") was historically a global provider of conferencing, collaboration, and AV streaming solutions for voice and visual communications. Following the October 24, 2025 disposition of substantially all operating assets and intellectual property to Biamp Systems, LLC (the "Asset Sale"), the Company no longer manufactures or sells products. Our continuing operations are now limited to (i) fulfilling warranty and technical support obligations for legacy products, (ii) maintaining public-company compliance and governance, (iii) collecting accounts receivable and recovering prepaid assets and (iv) evaluating and pursuing strategic alternatives, including a potential mergers or other transaction intended to maximize stockholder value.

------

[**Table of Contents**](#TOC)

**MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS**

In September 2025, the Company's Board of Directors approved a plan (the "Strategic Plan") to seek the sale of a significant portion of the Company's operating assets related to its product business, reduce the Company's continuing operations to warranty and product support, and position the Company as a reverse merger vehicle for a possible strategic transaction (a "Strategic Transaction"). Accordingly, as of September 30, 2025, we classified the related disposal group of assets as held for sale and measured it at the lower of carrying amount or fair value less costs to sell; the assets held for sale were sold in October 2025 and certain assets and liabilities related to discontinued operations remained after the October 2025 sale (see Note 2 — Discontinued Operations and Assets Held for Sale). Because the planned disposal represents a strategic shift that will have a significant effect on our operations and financial results, we present the results of that component as discontinued operations for all periods shown. Accordingly, this MD&A discusses continuing operations separately from discontinued operations where relevant.

Strategic actions during 2025 and 2026

* **July 2025** – Issuance of Class A Redeemable Preferred Stock as a special stock dividend and automatic conversion of the $3.0 million convertible note into Class B Convertible Preferred Stock (see Notes 3 and 4).

* **September 2025** – Repurchase and cancellation of all then-outstanding warrants (see Note 5).

* **October 24, 2025** – Completion of the Asset Sale to Biamp Systems, LLC for $3.0 million in cash. The transaction represented a strategic shift that had a major effect on the Company's operations and financial results. The results of the disposed component are presented as discontinued operations for all periods presented (see Note 2).

* **March 2, 2026** – Private placement with First Finance Ltd. (largest stockholder) for 437,500 shares and a warrant to purchase 437,500 additional shares (see Note 11).

* **March 9, 2026** – Repurchase of 24,155 warrants from CVI Investments, Inc. (see Note 5).

* **April 1, 2026** – Transition of CEO Derek Graham to a consulting arrangement (see Note 15).

* **April 7, 2026** – Termination of the Edgewater Corporate Park lease and receipt of Nasdaq continued listing deficiency notice (see Notes 9 and 15).

* **April 10, 2026** – Board approval of Class A Preferred Stock redemption at par (April 21, 2026) (see Notes 3 and 15).

* **April 22, 2026** – Completion of reincorporation from Delaware to Nevada (see Note 1).

*Operating context*

Following the Asset Sale, our continuing operations generate minimal revenue and consist primarily of warranty support, collecting accounts receivable and recovering prepaid assets, public-company compliance costs, and restructuring activities. Management's primary focus is preserving liquidity, and evaluating strategic alternatives (including a potential reverse merger or other transaction) to maximize stockholder value. The Company has incurred net losses and used cash in operations, and substantial doubt exists about its ability to continue as a going concern (see Note 1 – Going Concern).

*Continuing operations and post-disposition plan*

Following the Asset Sale on October 24, 2025, our continuing operations are limited to (i) fulfilling warranty and technical support obligations for legacy products, (ii) maintaining public-company compliance and governance, (iii) collecting accounts receivable and recovering prepaid assets and (iv) evaluating and pursuing strategic alternatives. We do not expect to generate material revenue from continuing operations in the foreseeable future.

*Warranty support activities*

We retained responsibility for legacy product support and warranty obligations. The Company maintains a small technical support function and limited service inventory to honor these obligations. Any immaterial service or parts revenue, if recognized, is reported within continuing operations. We evaluate warranty accruals each period and adjust estimates based on observed claim rates and resolution costs.

------

[**Table of Contents**](#TOC)

*Corporate infrastructure and compliance*

We maintain a lean corporate staff, including accounting/finance, IT, and senior management (CEO/CFO). Ongoing costs include audit and tax services, legal and advisory fees, SEC reporting, D&O insurance, IT/licensing, and Board and compliance expenses.

*Monetization of residual assets and settlement of obligations*

Management's near-term priorities include monetizing any remaining assets, collecting receivables, settling liabilities, and completing the Class A Preferred redemption. All three facility leases were terminated by April 7, 2026 (see Note 9 and Note 15).

*Presentation and comparability*

Results of the disposed product business are presented as discontinued operations for all periods shown. Continuing operations primarily comprise warranty support, corporate and restructuring costs. The balance sheet reflects assets and liabilities related to discontinued operations. The statement of operations presents (loss) from continuing operations separately from gain (loss) from discontinued operations, net of tax, and basic/diluted income (loss) per share is shown for continuing operations, discontinued operations, and total (see Note 7 — Income (Loss) Per Share).

*Critical accounting estimates*

The classification of the disposal group of assets as held for sale and presentation as discontinued operations required management to make significant estimates, including the measurement of fair value less costs to selloff the disposal group of assets (ASC 360) and the warranty obligation retained by the Company (ASC 460). These estimates use assumptions regarding market participant pricing, transaction costs, expected claim rates and unit repair costs. Actual results could differ materially from these estimates.

*Liquidity and going-concern considerations*

We have incurred net losses and used cash in operations for the periods presented. Our ability to meet obligations as they come due depends on the timing and magnitude of cash from residual asset monetization, collections, and access to additional financing or a Strategic Transaction. These conditions raise substantial doubt about our ability to continue as a going concern within one year after the issuance of these financial statements. Management's plans include managing warranty exposure, collecting accounts receivable and recovering prepaid assets, and pursuing strategic alternatives. See Note 1 — Going Concern for additional information.

*Key risks and uncertainties*

Execution of the restructuring and any Strategic Transaction involves risks, including warranty claim variability, timing of asset monetization, and the cost and availability of essential public-company services. Actual outcomes may differ materially from current expectations.

*Off-balance sheet arrangements*

We had no off-balance sheet arrangements as of March 31, 2026.

*Deferred Product Revenue*

Deferred product revenue decreased to $0 at both March 31, 2026 and December 31, 2025.

A detailed discussion of our results of operations follows below.

------

[**Table of Contents**](#TOC)

**MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS**

***Results of Operations for the three months ended March 31, 2026***

Following the Asset Sale on October 24, 2025, the Company's continuing operations generate minimal revenue and consist primarily of warranty support, public-company compliance, and restructuring costs. The majority of the Company's historical operations are now presented as discontinued operations (see Note 2):

*Continuing Operations*

---

| | | | |
|:---|:---|:---|:---|
|  | **Three months ended March 31,** | **Three months ended March 31,** | **Three months ended March 31,** |
| (dollars in thousands) | **2026** | **2025** | **Change Favorable (Adverse) in %** |
| Revenue  | $— | $— |  |
| Cost of goods sold  | 70 | 27 | (159) |
| Gross profit (loss)  | (70) | (27) | (159) |
| Sales and marketing  |  |  |  |
| Research and product development  |  |  |  |
| General and administrative  | 780 | 799 | 2 |
| Total operating expenses  | 780 | 799 | 2 |
| Operating loss  | (850) | (826) | (3) |
| Other income (expense), net  |  | 12 | (100) |
| Loss before income taxes  | (850) | (814) | (4) |
| Provision (benefit) for income taxes  |  |  |  |
| Net loss from continuing operations  | $(850) | $(814) | (4) |

---

***Overview***

Continuing operations in Q1 2026 primarily comprise corporate activities (public-company reporting, governance, and compliance), warranty support for legacy products, and restructuring actions. We recorded no product revenue in continuing operations for the three months ended March 31, 2026.

*Costs of Goods Sold and Gross Profit (Loss)*

Cost of goods sold in continuing operations reflects warranty-related parts and labor and immaterial service inventory usage. With no revenue in continuing operations for the periods presented, gross margin percentages are not meaningful; the period-over-period dollar changes reflect timing and volume of warranty claims and repairs.

*Operating Expenses*

**General & administrative (G&A)** - General & administrative (G&A) expenses in Q1 2026 were driven primarily by legal, advisory, and regulatory fees associated with the strategic review, disposition process, audit and tax fees, D&O insurance, and incremental accounting and compliance costs. S&M and R&D expenses in continuing operations were immaterial following the classification of the product business as held for sale.

**Sales & marketing (S&M) and research & development (R&D)** - Following classification of the product business as held for sale, S&M and R&D expenses in continuing operations were immaterial for the periods presented. To the extent severance or other exit costs were recognized in the quarter, such costs are reflected in the relevant operating expense caption in the period incurred.

**Restructuring/exit costs** - To the extent actions met ASC 420 recognition criteria, we recorded employee termination or contract termination costs; otherwise, such costs will be recognized when probable and reasonably estimable.

------

[**Table of Contents**](#TOC)

*Other income (expense), net*

Other income (expense), net reflects interest income on cash equivalents, interest expense on the convertible note through its conversion on July 21, 2025, and immaterial gains/losses on asset disposals related to restructuring activities.

*Income taxes*

We maintained a full valuation allowance against US federal and state deferred tax assets in both periods due to cumulative losses and uncertainty of realization. Accordingly, we did not recognize an income tax benefit for losses in continuing operations.

*Discontinued Operations*

---

| | | | |
|:---|:---|:---|:---|
|  | **Three months ended March 31,** | **Three months ended March 31,** | **Three months ended March 31,** |
| (dollars in thousands) | **2026** | **2025** | **Change Favorable (Adverse) in %** |
| Revenue | $— | $2313 | (100) |
| Cost of goods sold | 88 | 2165 | 96 |
| Gross profit (loss) | (88) | 148 | (159) |
| Total operating expenses  | 264 | 2168 | 88 |
| Operating loss | (430) | (2020) | 79 |
| Income /(Loss) from discontinued operations, net of tax | $363 | $(2020) | 118 |

---

Revenue in discontinued operations declined to $0 in Q1 2026 compared to $2,313 in Q1 2025, reflecting the completion of the Asset Sale in October 2025. See Note 2 — Discontinued Operations and Assets Held for Sale for additional details on the components of discontinued operations.

------

[**Table of Contents**](#TOC)

***Costs of Goods Sold and Gross Profit***

Cost of goods sold includes expenses associated with finished goods purchased from outsourced manufacturers, the repackaging of our products, our manufacturing and operations organization, property and equipment depreciation, warranty expense, freight expense, royalty payments, and the allocation of overhead expenses.

Our gross profit decreased from $148 during 2025-Q1 to a loss of $88 during 2026-Q1.

The reduction in gross profit reflects the completion of the Asset Sale in October 2025. See Note 2 — Discontinued Operations and Assets Held for Sale for additional details on the components of discontinued operations.

***Operating Expenses***

Operating expenses include sales and marketing ("S&M") expenses, research and product development ("R&D") expenses and general and administrative ("G&A") expenses. Total operating expenses in 2026-Q1 were $264 compared to $2,168 in 2025-Q1. The following contains a more detailed discussion of expenses related to sales and marketing, research and product development, general and administrative, and other items.

***<u>Sales and Marketing</u>*** - S&M expenses include selling, customer service, and marketing expenses such as employee-related costs, allocations of overhead expenses, trade shows, and other advertising and selling expenses.

S&M expenses were $33 in Q1-2026, compared to $1,116 in Q1-2025. Both comparisons are the result of decreased sales commissions on fewer sales as well as lowered marketing spend inclusive of the reduction in force completed in Q3 of 2025.

***<u>Research and Product Development</u>*** - R&D expenses include research and development, product line management, engineering services, and test and application expenses, including employee-related costs, outside services, expensed materials, depreciation, and an allocation of overhead expenses.

R&D expenses were $9 in Q1-2026, compared to $691 in Q1-2025. The decrease in comparing the quarterly results was due to a decrease in headcount.

***<u>General and Administrative</u>*** - G&A expenses include employee-related costs, allocations of overhead expenses, litigation costs, and corporate administrative costs, including costs related to operational teams.

G&A expenses were $222 in Q1-2026, compared to $361 in Q1-2025. The decreases were due to decreased expenses related to the exploration of strategic alternatives and closing down facilities.

***Other income (expense), net***

Other income (expense), net includes gain or loss on disposal of assets and impairment charges related to assets being held for sale. Other income for the three months ended March 31, 2026 included a $78 charge for expenses related to closure of foreign subsidiaries, compared to $0 for the three months ended March 2025.

***Provision for income taxes***

During the three months ended March 31, 2026, the Company recorded an income tax benefit of $793 (recorded in discontinued operations) resulting from the reversal of unrecognized tax benefits (FIN 48 reserves). This reversal occurred because the statute of limitations expired for certain tax years, and the underlying tax positions were no longer subject to IRS review. For the three months ended March 31, 2025, the Company did not recognize any tax benefit from its losses due to the establishment of a full valuation allowance on its net deferred tax assets.

*Net Loss and Outlook*

Net loss for the first quarter of 2026 was $487, compared to a net loss of $2,834 in the first quarter of 2025. The improvement was primarily driven by a one-time income tax benefit of $793 (recorded in discontinued operations) from the release of uncertain tax positions, partially offset by the absence of revenue-generating operations following the October 2025 Asset Sale to Biamp Systems.

Looking ahead, the Company's continuing operations are expected to consist primarily of warranty servicing and technical support for legacy products, along with ongoing public company compliance and governance costs. We will continue to evaluate warranty claims experience and adjust our reserves as appropriate. In parallel, management is actively pursuing strategic alternatives, completed the redemption of the Class A Redeemable Preferred Stock on April 21, 2026, collecting accounts receivable and recovering prepaid assets, and continues to evaluate potential reverse merger or other value-enhancing transactions. We expect these activities to remain the primary focus for the remainder of 2026.

------

[**Table of Contents**](#TOC)

**LIQUIDITY AND CAPITAL RESOURCES**

As of March 31, 2026, cash and cash equivalents were $1,053 compared to $739 as of December 31, 2025. Working capital was minimal at both dates.

Cash used in operating activities was approximately $680 in the three months ended March 31, 2026, compared to $2,644 in the three months ended March 31, 2025. The decrease in cash used was primarily due to the absence of operating activities following the Asset Sale.

Cash provided by (used in) investing activities was $0 for the three months ended March 31, 2026, compared to $0 used in the prior-year period.

Cash provided by financing activities in the three months ended March 31, 2026 was $1,728, compared to $1,000 in the three months ended March 31, 2025. Both provision to cash were the result of common stock sales.

For a detailed discussion of liquidity and going-concern considerations, including management's plans and the substantial doubt about the Company's ability to continue as a going concern, see Note 1 – Going Concern.

In furtherance of the Asset Sale pursuit, the Company completed a one-time special stock dividend of Class A Redeemable Preferred Stock, payable July 18, 2025 to holders of record of our common stock on July 11, 2025, which entitles holders of the Class A Redeemable Preferred Stock to 100% of net proceeds from any Asset Sale upon redemption (see Notes 3 and 15 – the redemption occurred on April 21, 2026 at par value of $2). This structure aligns stockholder interests with the strategic process but depends on the successful completion of the Asset Sale for value realization. See Note 3 – Class A Redeemable Preferred Stock.

As of March 31, 2026, First Finance Ltd. beneficially owned approximately 61.34% of our common stock on an as-converted basis and has the right to nominate two directors to our Board. This concentration may influence strategic decisions, including the ongoing restructuring and possible Strategic Transactions, and could affect our ability to attract alternative financing or partners.

As of March 31, 2026, we had no open purchase orders.

As of March 31, 2026, we had inventory totaling $333. This compares to total inventories of $353 as of December 31, 2025.

**Contractual Obligations and Commitments**

The following table summarizes our contractual obligations as of March 31, 2026 (in thousands):

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Payment Due by Period** | **Payment Due by Period** | **Payment Due by Period** | **Payment Due by Period** | **Payment Due by Period** |
|  | **Total** | **Less Than**<br> **1 Year** | **1-3 Years** | **3-5 Years** | **More than 5**<br> **years** |
| Operating lease obligations  | $360 | $185 | $175 | $— | $— |
| Purchase obligations  |  |  |  |  |  |
| Total  | $360 | $185 | $175 | $— | $— |

---

**OFF-BALANCE SHEET ARRANGEMENTS**

We have no off-balance-sheet arrangements that have or are reasonably likely to have a current or future material effect on our financial condition, changes in financial conditions, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources, results of operations or liquidity.

**CRITICAL ACCOUNTING POLICIES AND ESTIMATES**

Our critical accounting policies and estimates are disclosed in our Annual Report on Form 10-K for the year ended December 31, 2025. There have been no material changes to our critical accounting policies and estimates during the three months ended March 31, 2026, other than (i) the presentation of discontinued operations as described in Note 2 and (ii) the reclassification of Class A Redeemable Preferred Stock from temporary equity to a current liability (see Note 3).

**RECENT ACCOUNTING PRONOUNCEMENTS**

See Note 1 — Significant Accounting Policies and Recent Accounting Pronouncements for a discussion of recently issued accounting standards and their expected impact on our financial statements.

------

[**Table of Contents**](#TOC)

[**Item 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK**](#)

The Company is not exposed to significant market risk. Following the Asset Sale on October 24, 2025, the Company has minimal operations, no variable-rate debt, and limited foreign currency exposure. The Company's primary financial instruments consist of cash and cash equivalents and the Class A Redeemable Preferred Stock liability (classified as a current liability at par value). Changes in interest rates or foreign currency exchange rates are not expected to have a material effect on the Company's financial condition or results of operations.

[**ITEM 4. CONTROLS AND PROCEDURES**](#)

*Evaluation of Disclosure Controls and Procedures*

We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), is recorded, processed, summarized and reported within the time periods specified in the SEC's rules and forms and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure.

Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, we conducted an evaluation of the effectiveness of our disclosure controls and procedures as of the end of the period covered by this report. Based on that evaluation, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures were effective as of March 31, 2026.

Changes in Internal Control Over Financial Reporting

There were no changes in our internal control over financial reporting during the quarter ended March 31, 2026 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

[**PART II - OTHER INFORMATION**](#TOC)

[**Item 1. LEGAL PROCEEDINGS**](#TOC)

From time to time, we are involved in various legal proceedings and other matters arising in the normal course of business. We are not currently a party to any legal proceeding that, if determined adversely to us, would have a material adverse effect on our financial condition or results of operations.

[**Item 1A. RISK FACTORS**](#TOC)

The risk factors under the heading "Risks Relating to our Business" set forth in Part I, Item 1A of the our Annual Report on Form 10-K for the year ended December 31, 2025 as filed with the SEC on March 31, 2026 are hereby supplemented with the following additional risk factors:

*We are at risk for being delisted from the NASDAQ Capital Market for noncompliance with Nasdaq's Continued Listing Standards* 

On April 7, 2026, we received a letter from Nasdaq informing us that we are not in compliance with the continued listing standards under Nasdaq Marketplace Rule 5550(b). We have 45 calendar days (until May 22, 2026) to submit a compliance plan. If we are unable to regain compliance with Nasdaq's continued listing standards within any applicable cure period, our common stock could be subject to delisting from the Nasdaq Capital Market. Delisting of our common stock from Nasdaq could significantly reduce the liquidity and market price of our common stock and could make it more difficult for us to access the capital markets on acceptable terms, if at all. Even after we receive a notice of non-compliance, we may not be able to regain compliance within the timeframe provided by Nasdaq. Alternative markets, such as the over-the-counter markets, generally have less liquidity and visibility than Nasdaq, and trading on such markets could adversely affect the ability of stockholders to sell their shares at a desired price.

The risk factors under the heading "Risks Relating to Share Ownership" set forth in Part I, Item 1A of the our Annual Report on Form 10-K for the year ended December 31, 2025 as filed with the SEC on March 31, 2026 are hereby supplemented with the following additional risk factors:

*Our Nevada Reincorporation May Affect the Rights of our Stockholders with Respect to Certain Corporation Actions*

On April 22, 2026, we completed our reincorporation from Delaware to Nevada by conversion. As a Nevada corporation, we are subject to Nevada corporate law, which differs from Delaware law in certain respects, including with respect to stockholder rights, fiduciary duties of directors and officers, and the ability to adopt certain anti-takeover provisions. These differences could affect the rights of our stockholders and the governance of the Company. A discussion of these differences and related risks is set forth in our definitive information statement on Schedule 14C filed with the SEC on March 31, 2026 under the Heading "What Changes After Nevada Reincorporation?".

------

[**Table of Contents**](#TOC)

[**Item 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS**](#TOC)

(a) None

(b) Not applicable.

(c) None.

[**Item 3. DEFAULTS UPON SENIOR SECURITIES**](#TOC)

(a) Not applicable.

(b) Not applicable.

[**Item 4. MINE SAFETY DISCLOSURES**](#TOC)

Not applicable.

[**Item 5. OTHER INFORMATION**](#TOC)

(a) Not applicable.

(b) Not applicable.

(c) Not applicable.

------

[**Table of Contents**](#TOC)

**Item 6. [EXHIBITS](#TOC)**

---

| | |
|:---|:---|
| **Exhibit No.** | **Title of Document** |
| 3.1 | [Articles of Incorporation (filed as Exhibit 3.1 to the Company's Current Report on Form 8-K as filed with the SEC on April 23, 2026 and incorporated herein by reference).](http://www.sec.gov/Archives/edgar/data/840715/000175392626000720/ex31_1.htm) |
| 3.2 | [Bylaws (filed as Exhibit 3.1 to the Company's Current Report on Form 8-K as filed with the SEC on April 23, 2026 and incorporated herein by reference).](http://www.sec.gov/Archives/edgar/data/840715/000175392626000720/ex31_1.htm) |
| 4.1 | [Form of Warrant (filed as Exhibit 4.1 to the Company's Current Report on Form 8-K as filed with the SEC on March 5, 2026 and incorporated herein by reference).](http://www.sec.gov/Archives/edgar/data/840715/000175392626000443/ex41_1.htm) |
| 10.1 | [Lease Termination Agreement dated as of April 7, 2026 by and between Edgewater Corporate Park, LLC and ClearOne, Inc. (filed as Exhibit 10.1 to the Company's Current Report on Form 8-K as filed with the SEC on April 13, 2026 and incorporated herein by reference).](http://www.sec.gov/Archives/edgar/data/840715/000175392626000649/ex101_1.htm) |
| 10.2 | [Letter Agreement dated April 1, 2026 by and between ClearOne, Inc. and Derek Graham (filed as Exhibit 10.1 to the Company's Current Report on Form 8-K as filed with the SEC on April 3, 2026 and incorporated herein by reference).](http://www.sec.gov/Archives/edgar/data/840715/000175392626000620/ex101_1.htm) |
| 10.3 | [Warrant Repurchase Agreement, dated March 9, 2026, by and between ClearOne, Inc. and CVI Investments, Inc. (filed as Exhibit 10.1 to the Company's Current Report on Form 8-K as filed with the SEC on March 13, 2026 and incorporated herein by reference).](http://www.sec.gov/Archives/edgar/data/840715/000175392626000473/ex101_1.htm) |
| 10.4 | [Securities Purchase Agreement dated as of March 2, 2026 by and between First Finance, Ltd. and ClearOne, Inc. (filed as Exhibit 10.1 to the Company' s Current Report on Form 8-K as filed with the SEC on March 5, 2026 and incorporated herein by reference).](http://www.sec.gov/Archives/edgar/data/840715/000175392626000443/ex101_2.htm) |
| 10.5 | [Registration Rights Agreement dated as of March 2, 2026 by and between First Finance, Ltd. and ClearOne, Inc. (filed as Exhibit 10.2 to the Company' s Current Report on Form 8-K as filed with the SEC on March 5, 2026 and incorporated herein by reference).](http://www.sec.gov/Archives/edgar/data/840715/000175392626000443/ex102_3.htm) |
| 10.6# | [Settlement Agreement and Waiver of Claims (filed as Exhibit 10.1 to the Company's Current Report on Form 8-K as filed with the SEC on January 14, 2026 and incorporated herein by reference).](http://www.sec.gov/Archives/edgar/data/840715/000175392626000244/ex101_1.htm) |
| 31.1\* | [Section 302 Certification of Chief Executive Officer (filed herewith)](ex311_1.htm) |
| 31.2\* | [Section 302 Certification of Principal Financial Officer (filed herewith)](ex312_2.htm) |
| 32.1\* | [Section 906 Certification of Chief Executive Officer (filed herewith)](ex321_3.htm) |
| 32.2\* | [Section 906 Certification of Principal Financial Officer (filed herewith)](ex322_4.htm) |
| 101.INS | XBRL Instance Document (filed herewith)  |
| 101.SCH | XBRL Taxonomy Extension Schema (filed herewith) |
| 101.CAL | XBRL Taxonomy Extension Calculation Linkbase (filed herewith) |
| 101.DEF | XBRL Taxonomy Extension Definitions Linkbase (filed herewith) |
| 101.LAB | XBRL Taxonomy Extension Label Linkbase (filed herewith) |
| 101.PRE | XBRL Taxonomy Extension Presentation Linkbase (filed herewith) |
| 104.1 | The cover page of this Quarterly Report on Form 10-Q, formatted in Inline XBRL. |
| \* Filed herewith.<br> # Certain portions of this exhibit (indicated by "[\*\*\*]") have been omitted pursuant to Item 601(a)(6) of Regulation S-K. | \* Filed herewith.<br> # Certain portions of this exhibit (indicated by "[\*\*\*]") have been omitted pursuant to Item 601(a)(6) of Regulation S-K. |

---

------

[**Table of Contents**](#TOC)

**SIGNATURES**

Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | ClearOne, Inc.,<br> (Registrant) | ClearOne, Inc.,<br> (Registrant) |
|  | By: | */s/ Derek L. Graham* |
| May 15, 2026 |  | Derek L. Graham<br> Chief Executive Officer<br> *(Principal Executive Officer)* |
|  | By: | */s/ Simon Brewer* |
| May 15, 2026 |  | Simon Brewer<br> Chief Financial Officer<br> *(Principal Accounting and Principal Financial Officer)* |

---

------

## Exhibit 31.1

**EXHIBIT 31.1**

**CERTIFICATION**

I, Derek L. Graham, certify that:

1. I have reviewed this quarterly report of ClearOne, Inc. on Form 10-Q;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting.

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | | |
|:---|:---|:---|
|  | By: | */s/ Derek L. Graham* |
| May 15, 2026 |  | Derek L. Graham<br> Chief Executive Officer<br> *(Principal Executive Officer)* |

---

## Exhibit 31.2

**EXHIBIT 31.2**

**CERTIFICATION**

I, Simon Brewer, certify that:

1. I have reviewed this quarterly report of ClearOne, Inc. on Form 10-Q;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting.

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | | |
|:---|:---|:---|
|  | By: | */s/Simon Brewer* |
| May 15, 2026 |  | Simon Brewer<br> Chief Financial Officer<br> *(Principal Accounting and Principal Financial Officer)* |

---

## Exhibit 32.1

**EXHIBIT 32.1**

**CERTIFICATION OF CHIEF EXECUTIVE OFFICER**

**Pursuant to 18 U.S.C. Section 1350, As adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002**

I, Derek L. Graham, certify, to my best knowledge and belief, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of ClearOne, Inc. on Form 10-Q for the quarter ended March 31, 2026 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Quarterly Report on Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of ClearOne, Inc.

---

| | | |
|:---|:---|:---|
|  | By: | */s/ Derek L. Graham* |
| May 15, 2026 |  | Derek L. Graham<br> Chief Executive Officer<br> *(Principal Executive Officer)* |

---

## Exhibit 32.2

**EXHIBIT 32.2**

**CERTIFICATION OF CHIEF FINANCIAL OFFICER**

**Pursuant to 18 U.S.C. Section 1350, As adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002**

I, Simon Brewer, certify, to my best knowledge and belief, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of ClearOne, Inc. on Form 10-Q for the quarter ended March 31, 2026, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Quarterly Report on Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of ClearOne, Inc.

---

| | | |
|:---|:---|:---|
|  | By: | */s/ Simon Brewer* |
| May 15, 2026 |  | Simon Brewer<br> Chief Financial Officer<br> *(Principal Accounting and Principal Financial Officer)* |

---